Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
RESEARCH TOOLSreports
BioVaxys Technology (BVAXF) Stock Price & Analysis
29 Followers
BVAXF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.08
Previous Close$0.06
Volume1.00K
Average Volume (3M)155.45K
Market Cap
$8.66M
Enterprise Value$8.50M
Total Cash (Recent Filing)C$423.00
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)-0.7
Beta1.98
Next Earnings
Jun 27, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding148,014,057
10 Day Avg. Volume61,283
30 Day Avg. Volume155,446
Standard Deviation0.88
R-Squared0.06
Alpha0.10
Financial Highlights & Ratios
Price to Book (P/B)-12.74
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-124.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioVaxys Technology News
PremiumCompany Announcements
BioVaxys Filing Delays Extend MCTO Deadline
PremiumCompany Announcements
Innovative Fish Contraceptive Vaccine Enters Field Trials
PremiumCompany Announcements
BioVaxys Delays Financial Filings, Aims for Compliance
PremiumCompany Announcements
BioVaxys Gains U.S. Patent, Advances Global Filings
PremiumCompany Announcements
BioVaxys Plans Capital Boost with Private Placement
PremiumCompany Announcements
BioVaxys Reports Delay in Financial FilingsPremiumCompany Announcements
BioVaxys Receives Cease Trade Order Amid Audit Delays
PremiumCompany Announcements
BioVaxys Continues Bi-Weekly Update Amid Filing DelayOptions Prices
Currently, No data available
---
Ownership Overview
21.43% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
78.57% Public Companies and
Individual Investors
BVAXF FAQ
What was BioVaxys Technology’s price range in the past 12 months?
BioVaxys Technology lowest stock price was <$0.01 and its highest was $0.07 in the past 12 months.
What is BioVaxys Technology’s market cap?
Currently, no data Available
When is BioVaxys Technology’s upcoming earnings report date?
BioVaxys Technology’s upcoming earnings report date is Jun 27, 2024 which is in 63 days.
How were BioVaxys Technology’s earnings last quarter?
Currently, no data Available
Is BioVaxys Technology overvalued?
According to Wall Street analysts BioVaxys Technology’s price is currently Overvalued.
Does BioVaxys Technology pay dividends?
BioVaxys Technology does not currently pay dividends.
What is BioVaxys Technology’s EPS estimate?
BioVaxys Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioVaxys Technology have?
BioVaxys Technology has 145,111,820 shares outstanding.
What happened to BioVaxys Technology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BioVaxys Technology?
Currently, no hedge funds are holding shares in BVAXF
---
BioVaxys Technology Stock Smart Score
Company Description
BioVaxys Technology
Lions Bay Mining Corp is a Canada based mineral exploration company. The company currently retains five mineral properties, with four in the Yukon Canada and one in Nevada. The Yukon properties include the, HY Jay, VM, VBA and Big properties and the Nevada property is located at Fish Lake in Esmeralda County.
---
Technical Analysis
---